Korro Bio, Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

Korro Bio, Inc. reported Cash And Cash Equivalents At Carrying Value of $21.82 million for the year ending 2025.

  • Korro Bio, Inc. showed a decrease of -60.8% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from Korro Bio, Inc.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
  • XBRL data for this metric is available from 2018 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 9 years of available data (2018 to 2025), Korro Bio, Inc.'s Cash And Cash Equivalents At Carrying Value has declined by 48.3%.
  • Historical annual values: Fiscal year 2025: $21.82 million | Fiscal year 2024: $55.64 million | Fiscal year 2023: $166.15 million | Fiscal year 2023: $36.60 million | Fiscal year 2022: $36.33 million | Fiscal year 2021: $79.64 million | Fiscal year 2020: $220.34 million | Fiscal year 2019: $200.16 million | Fiscal year 2018: $42.19 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: